Research chemically modified IL2s for cancer immunotherapy.
Recombinant proteins have become an important class of biological therapies to treat a range of human diseases including cancer and diabetes. In effort to increase the capability of protein therapeutics, Dr. Lin's lab has been working on recombinant proteins containing novel chemical functionalities using a genetic code expansion strategy. This undergraduate research project seeks to develop covalent interleukin 2 (IL2) analogs that display selective IL2 receptor subunits for cancer immunotherapy applications.
Professional, presentation-ready poster or professional research report.
|Length of commitment||About 3-5 months|
|Start time||Fall 2021|
|Level of collaboration||Small group project (2-3 students) |
|Benefits||Research experience; academic credit|
|Who is eligible||Juniors and seniors who have taken CHE 201/202 or CHE 203/204|
Once you begin the digital badge series, you will have access to all the necessary activities and instructions. Your mentor has indicated they would like you to also complete the specific preparation activities below. Please reference this when you get to Step 2 of the Preparation Phase.